Segmentation by type categorizes Orthopedic Prosthetics into modular, custom‑fabricated, microprocessor‑controlled, passive, and active systems. Modular prostheses, which use standardized interchangeable components, capture the bulk of the market (≈60 %) because of cost efficiency, streamlined inventory, and rapid surgical implantation. Custom‑fabricated devices, tailored to patient‑specific anatomy through imaging and additive manufacturing, hold about 20 % of sales, driven by complex deformities and demand for optimal fit. Microprocessor‑controlled prostheses, incorporating sensors and actuators for adaptive gait, represent roughly 10 % of revenue, reflecting higher unit price and limited but expanding adoption in high‑functioning patients. Passive prostheses, relying on mechanical joints without active control, account for ≈5 % of the market, primarily in low‑resource settings. Active prosthetic systems, integrating powered actuation for enhanced mobility, contribute the remaining ≈5 % and are growing as battery and control technologies mature. This type‑based taxonomy clarifies how product differentiation influences overall market valuation.